[Webinar] Eliminate the risk of not achieving your goals! “Regional Collaboration DCT” strategy to accelerate case registration
Press
Greetings for the 9th term
Greetings
as we enter our 9th year Thank you for your continued support of Buzzreach.
Today marks our 9th year since our founding. Since
our founding in June 2017, we have been working to streamline new drug development (clinical trials) as a platform connecting pharmaceutical companies, medical institutions, and patients, with the mission of “providing new options for as many patients as possible through the power of technology.”
To date, we have been working to create an environment in which as many clinical trials and clinical research as possible can be carried out more efficiently through our SaaS-based clinical trial support tool “Study Works®︎,” which has been introduced to over 30 facilities, support for subject recruitment using partner sites at over 700 facilities, promotion of DCT (decentralized clinical trials), and support for clinical trial information disclosure using “Search My Trial (SMT),” which is used by Pfizer, AstraZeneca , Maruho, Kyoto University Hospital (iACT), and others .
We will continue to use the power of technology to solve the challenges of new drug development (clinical trials), which typically takes 10 years, and will continue to work hard to achieve our company’s mission of “using the power of technology to provide new options to as many patients as possible.”
Once again, we would like to express our sincere gratitude for your support thus far, and all of our staff hope that you will continue to provide us with your guidance and support in the future.
Takateru Inokawa, CEO of
Buzzreach Inc.
Click here for the latest press release
- “StudyWorks,” which promotes the digitalization of clinical trial operations, has been adopted by over 30 facilities, and now also supports DCT operation management
- The “partner site” network, which is responsible for building clinical trial infrastructure in the DCT era, has surpassed 737 facilities across 29 diseases.
- Kanazawa University Hospital promotes clinical trial digital transformation by introducing StudyWorks® to streamline clinical trial operations and strengthen information sharing systems
- Buzzreach releases latest report showing declining vaccination rates among seniors
Related Articles
-
-
We will be exhibiting a corporate booth at the 57th Annual Meeting of the Japanese Society of Pediatric Respiratory Medicine.
-
Guidance and request for cooperation regarding the handling of clinical trial information when using the clinical trial support system “StudyWorks”
-
Published an article on the application of DCT (Decentralized Clinical Trials) in Japan and the future of DX in the clinical trial industry
-
Representative Ikawa will be speaking at the 22nd DIA Japan Annual Meeting 2025, and the company will have a booth.
-
A paper by our representative, Inogawa, was published in Volume 42, Issue 3 of Neurotherapeutics, the journal of the Japanese Society of Neurotherapeutics.
-
[Webinar] DCT model created by medical institutions in collaboration with partner sites
-
We will be co-hosting a seminar and exhibiting a corporate booth at the ARO Council’s 12th Academic Conference in Chiba.
-
We will be co-hosting a seminar and exhibiting a corporate booth at the 25th Conference on CRC and Clinical Trials 2025 in Omiya.
-
The 9th Kickoff Meeting was held.